Oracle Investment Management

Latest statistics and disclosures from Oracle Investment Management's latest quarterly 13F-HR filing:

Companies in the Oracle Investment Management portfolio as of September 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Tesaro 27.79 1.13M -26% 129.10
Mazor Robotics Ltd. equities 20.86 2.22M -10% 49.37
Quidel Corporation (QDEL) 20.25 2.43M -4% 43.86
Pacific Biosciences of California (PACB) 8.68 8.69M +5% 5.25
Opko Health (OPK) 4.75 3.64M 6.86
Amarin Corporation (AMRN) 4.20 6.30M 3.50
Vermillion (VRML) 3.37 9.83M +6% 1.80
Biolase Technology (BLTI) 2.09 18.32M +25% 0.60
Accelr8 Technology Corporation (AXK) 1.93 5.17M +9% 1.96
shares Agenus Inc 1.34 1.60M 4.41
Epizyme 1.34 369403 +26% 19.05
Adaptimmune Therapeutics 1.09 701861 NEW 8.19
Intrexon 0.71 195000 -71% 19.01
Contrafect 0.46 2.18M +84% 1.11
Biogen Idec (BIIB) 0.38 6368 313.13
Accuray Incorporated (ARAY) 0.36 473256 NEW 4.00
Arena Pharmaceuticals 0.31 64373 NEW 25.51
NxStage Medical (NXTM) 0.06 2.07M -24% 0.15
Aquabounty Technologies 0.02 12204 7.13
Second Sight Med Prods 0.01 50804 1.20

Past 13F-HR SEC Filings by Oracle Investment Management

View All Filings